MAXIGEN BIOTECH INCMM

MAXIGEN BIOTECH INC

51.7TWDD
−0.6−1.15%
At close at Jan 10, 06:36 UTC
TWD
No trades
See on Supercharts

1783 fundamentals

Key facts

Market capitalization‪4.61 B‬TWD
Founded1998
CEOJing Ting Chen
Websitembi.com.tw
About

Maxigen Biotech, Inc. engages in the business of collagen purification; research and development, production, and selling implantable medical device; and producing, manufacturing, wholesaling, and retailing cosmetics. It operates through the following segments: Biomedical Products, Consumer Products, and Others. The Biomedical Products segment includes manufacturing and selling collagen and bone materials. The Consumer Products segment focuses on beauty care products. The company was founded on December 3, 1998 and is headquartered in Taoyuan, Taiwan.

Ownership
‪‪89.16 M‬‬
Free Float shares
‪‪65.78 M‬‬ (73.77%)
Closely held shares
‪‪23.38 M‬‬ (26.23%)
Free Float shares
‪‪65.78 M‬‬ (73.77%)
Closely held shares
‪‪23.38 M‬‬ (26.23%)
Capital structure
Market cap
‪‪4.61 B‬‬
Debt
‪‪20.00 K‬‬
Cash & equivalents
‪‪545.26 M‬‬
Enterprise value
‪‪4.06 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪4.61 B‬‬
Price to earning ratio (P/E)
30.04x
Price to sales ratio (P/S)
7.49x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
30.04x
Price to sales ratio (P/S)
7.49x
Valuation ratios
‪0.00‬
‪2.00‬
‪4.00‬
‪6.00‬
‪8.00‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪8.00‬
‪16.00‬
‪24.00‬
‪32.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪10%‬
‪17%‬
‪24%‬
‪31%‬
‪38%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Biomedical
Consumer
By country
Period: 2023
Taiwan
America
Asia
Europe
Other

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
‪0.00‬
‪‪35.00 M‬‬
‪‪70.00 M‬‬
‪‪105.00 M‬‬
‪‪140.00 M‬‬
Estimate
Earnings
Next:Mar 19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
‪0.00‬
‪0.08‬
‪0.16‬
‪0.24‬
‪0.32‬
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
57.15%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
1.93%
Last payment
0.999
Last ex-date
Jul 23, 2024
Dividend history
‪0.0%‬
‪0.8%‬
‪1.6%‬
‪2.4%‬
‪3.2%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.25‬
‪0.50‬
‪0.75‬
‪1.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪150.00 M‬‬
‪‪300.00 M‬‬
‪‪450.00 M‬‬
‪‪600.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬
‪‪800.00 M‬‬
Assets
Liabilities